See also this year's filing and all EDGAR filings for this company.
PDF Report 0000908259_2023_Oncotelic_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0000908259, Oncotelic Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 303,164 |
1 | IntangibleAssetsNetIncludingGoodwill | 12,071,376 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 23,742,279 |
4 | LiabilitiesCurrent | 16,923,407 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 4,853,664 |
9 | ResearchAndDevelopmentExpense | 756,910 |
10 | remainder_Expenses | 4,111,079 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 14,398,256 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 36,116,819 |
1 | Liabilities | 16,923,407 |
2 | Expenses | 9,721,653 |
3 | Revenues | 0 |
4 | StockholdersEquity | 19,193,412 |
5 | NetIncome | 4,676,603 |
6 | ComprehensiveNetIncome | 4,676,603 |
7 | BaseVar | 38,580,068 |
8 | EconomicCapitalRatio | 1.42 |